BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37511180)

  • 1. Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery.
    Plaja A; Teruel I; Ochoa-de-Olza M; Cucurull M; Arroyo ÁJ; Pardo B; Ortiz I; Gil-Martin M; Piulats JM; Pla H; Fina C; Carbó A; Barretina-Ginesta MP; Martínez-Román S; Carballas E; González A; Esteve A; Romeo M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer.
    Ye L; Zhou G; Zhou L; Wang D; Xiong S; Liu C; Zhang G
    J Int Med Res; 2023 Dec; 51(12):3000605231218557. PubMed ID: 38130127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
    Int J Gynaecol Obstet; 2024 Jan; 164(1):262-269. PubMed ID: 37496460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line.
    Espinós J; Aramendía JM; González-Martín A; Santisteban M; Sánchez L; Vizcay Á; Mínguez JÁ; Alcázar JL
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38856872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Preoperative Inflammation Markers on the Long-Term Outcomes in Peritoneal Carcinomatosis from Ovarian Cancer.
    Balescu I; Eftimie M; Petrea S; Diaconu C; Gaspar B; Pop L; Varlas V; Hasegan A; Martac C; Bolca C; Stoian M; Stroescu C; Zgura A; Bacalbasa N
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer.
    Weng CS; Huang WC; Chang CL; Jan YT; Chen TC; Lee J
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2114-2125. PubMed ID: 37503876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response: Comment on searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
    Int J Gynaecol Obstet; 2024 May; ():. PubMed ID: 38769662
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor: Searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Tang Y
    Int J Gynaecol Obstet; 2024 May; ():. PubMed ID: 38712447
    [No Abstract]   [Full Text] [Related]  

  • 9. Epithelial Ovarian Cancer: A Five Year Review.
    Arnaoutoglou C; Dampala K; Anthoulakis C; Papanikolaou EG; Tentas I; Dragoutsos G; Machairiotis N; Zarogoulidis P; Ioannidis A; Matthaios D; Perdikouri EI; Giannakidis D; Sardeli C; Petousis S; Oikonomou P; Nikolaou C; Charalampidis C; Sapalidis K
    Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37511995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer.
    O'Meara CH; Jafri Z; Khachigian LM
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota, Metabolome, and Body Composition Signatures of Response to Therapy in Patients with Advanced Melanoma.
    Vandoni G; D'Amico F; Fabbrini M; Mariani L; Sieri S; Casirati A; Di Guardo L; Del Vecchio M; Anichini A; Mortarini R; Sgambelluri F; Celano G; Serale N; De Angelis M; Brigidi P; Gavazzi C; Turroni S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Tumor-Based
    Borcoman E; Santana Dos Santos E; Genestie C; Pautier P; Lacroix L; Caputo SM; Cabaret O; Guillaud-Bataille M; Michels J; Auguste A; Leary A; Rouleau E
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cell plasticity during tumor progression, metastasis and response to therapy.
    Pérez-González A; Bévant K; Blanpain C
    Nat Cancer; 2023 Aug; 4(8):1063-1082. PubMed ID: 37537300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive evaluation of neutrophil extracellular traps signature predicts clinical outcomes and immunotherapy response in hepatocellular carcinoma.
    Xin H; Lai Q; Zhou Y; He J; Song Y; Liao M; Sun J; Li M; Zhang M; Liang W; Bai Y; Zhang Y; Zhou Y
    Front Immunol; 2023; 14():1134521. PubMed ID: 37520528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer.
    Ye W; Li M; Luo K
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between Mean Platelet Volume and Neutrophil-Lymphocyte Ratio and Liver Fibrosis in Patients with Chronic Hepatitis B.
    Ekmen MO; Uzman M
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512098
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis.
    González-Sierra M; Quevedo-Rodríguez A; Romo-Cordero A; González-Chretien G; Quevedo-Abeledo JC; de Vera-González A; González-Delgado A; Martín-González C; González-Gay MÁ; Ferraz-Amaro I
    Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Immunotherapy: A Promising New Standard of Care.
    Boydell E; Sandoval JL; Michielin O; Obeid M; Addeo A; Friedlaender A
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.
    Russo M; Panini N; Fabbrizio P; Formenti L; Becchetti R; Matteo C; Meroni M; Nastasi C; Cappelleri A; Frapolli R; Nardo G; Scanziani E; Ponzetta A; Bani MR; Ghilardi C; Giavazzi R
    Oncoimmunology; 2023; 12(1):2239035. PubMed ID: 37538353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis.
    Wang X; Peng H; Zhang G; Li Z; Du Z; Peng B; Cao P
    BMC Med Genomics; 2023 Jul; 16(1):178. PubMed ID: 37525242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.